FDA ruling on Pfizer's COVID jab for kids could come in November -Fauci

1 minute read

A vial labelled with the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine is seen in this illustration picture taken March 19, 2021. REUTERS/Dado Ruvic/Illustration

Register now for FREE unlimited access to Reuters.com

WASHINGTON, Sept 29 (Reuters) - U.S. health regulators' decision on whether to approve Pfizer (PFE.N)and BioNTech's (22UAy.DE) COVID-19 vaccine for children ages 5 to 11 could spill over into November if needed, the nation's top u.s. infectious disease official said on Wednesday.

Dr. Anthony Fauci, asked about Wall Street Journal reporting that expanded approval may not come next month depending on when the companies file a formal application, said the Food and Drug Administration was working expeditiously and that "if it goes into November, that's because it's necessary."

Register now for FREE unlimited access to Reuters.com
Reporting by Susan Heavey

Our Standards: The Thomson Reuters Trust Principles.